Eterna Therapeutics Inc (ERNA) — Free Cash Flow Generation Index

Latest as of September 2019: 1.00x

Eterna Therapeutics Inc (ERNA) has a Free Cash Flow Generation Index of 1.00x as of September 2019. Free cash flow of $88.00 Million represents 1% of operating cash flow ($88.00 Million). See how liquid is Eterna Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$88.00 Million
USD

Operating Cash Flow

$88.00 Million
USD

Capital Expenditures

$0.00
USD

Eterna Therapeutics Inc Free Cash Flow Generation Index (2009–2019)

Historical FCF Generation Index trend for Eterna Therapeutics Inc across 9 annual periods. Explore how well can Eterna Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Eterna Therapeutics Inc (2009–2019)

Year-by-year Free Cash Flow Generation Index for Eterna Therapeutics Inc. For the full company profile including market capitalisation, see ERNA stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 0.60x $1.65 Million $2.74 Million $1.09 Million ▲ +432.3%
2018 -0.18x $-247.00K $1.36 Million $1.61 Million ▲ +89.0%
2017 -1.64x $-903.00K $549.00K $1.45 Million ▲ +95.4%
2016 -35.52x $-817.00K $23.00K $840.00K ▼ -8491.4%
2013 0.42x $632.00K $1.49 Million $861.00K ▼ -1.9%
2012 0.43x $930.00K $2.16 Million $1.23 Million ▲ +124.3%
2011 -1.78x $-1.02 Million $574.00K $1.59 Million ▼ -433.6%
2010 0.53x $1.51 Million $2.83 Million $1.32 Million ▲ +124.8%
2009 0.24x $593.00K $2.50 Million $1.91 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).